Lercanidipine in patients with chronic renal failure: the ZAFRA Study

Lercanidipine in patients with chronic renal failure: the ZAFRA Study

Aim. To evaluate the safe use of a new calcium channel blocker, lercanidipine, in patients with chronic renal failure (CRF); the protective effect of calcium channel blocker on renal function in CRF patients previously treated with ACE inhibitors or angiotensin receptor blockers (ARB). Material and...

Full description

Saved in:
Bibliographic Details
Main Authors: N. R. Robles, J. Ocon, C. F. Gomez, M. Manjon, L. Pastor, J. Herrera, J. Villatoro, J. Calls, J. Torrijos, V. I. Rodríguez, M. M. A. Rodriguez, M. L. Mendez, A. Morey, F. I. Martinez, J. Marco, A. Liebana, B. Rincon, F. Tornero
Format: Article
Language:Russian
Published: «SILICEA-POLIGRAF» LLC 2010-08-01
Series:Кардиоваскулярная терапия и профилактика
Subjects:
lercanidipine
chronic renal failure
hypertension
Online Access:https://cardiovascular.elpub.ru/jour/article/view/2108
Tags: Add Tag
No Tags, Be the first to tag this record!
Login for hold and recall information

Internet

https://cardiovascular.elpub.ru/jour/article/view/2108

Similar Items